Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.
There has been rise in the incidence and prevalence of blood disorders such as hemophilia for the last few years. According to Centers for Disease Control & Prevention (CDC) in the U.S., around 400 newborn babies are estimated to have hemophilia every year. According to National Hemophilia Foundation of the U.S., around 400,000 people across the globe are estimated to be living with hemophilia. Another bleeding disorder called von Willebrand disease is estimated to have prevalence of 1% among general population. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools. This, in turn, is likely to fuel the global coagulometers market during the forecast period. Moreover, there is rising consumption of anti-coagulant drugs such as aspirin and heparin, coagulometers are used to monitor the treatment progress in those patients. This factor is likely to propel the coagulometers market from 2017 to 2025. However, high cost of these devices diverts potential users toward manual coagulation testing, which is projected to restrain the global coagulometers market during the forecast period.
The global coagulometers market can be segmented based on product type, technology, channel type, aesthetics, end-user, and region. In terms of product type, the market can be divided into automated and semi-automated coagulometers. Based on technology, the market can be divided into mechanical detection, photo-optical detection, electrochemical detection, and others. Most of the automated coagulometers work on the principle of photo-optical or electrochemical detection. This is estimated to result in a significant share held by these segments. The others segment includes combination of the above-mentioned technologies and other innovative methods. Based on channel type, the market can be segregated into single-channel, double-channel, and multichannel coagulometers. Multichannel coagulometers are widely used in diagnostic laboratories and hospitals, which is projected to result in a prominent share held by the multichannel coagulometers segment in the global coagulometers market.
Based on aesthetics, the global coagulometers market can be segmented into portable and bench-top models. Based on end-user, the market can be divided into hospitals & diagnostic laboratories, home care settings, and research institutes. The hospitals & diagnostic laboratories segment is projected to account for a major share of the global coagulometers market from 2017 to 2025.
Geographically, the global coagulometers market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to hold a major share of the global market during the forecast period, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global market during the forecast period, due to high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market in the region during the forecast period.
Major players operating in the global coagulometers market are HORIBA, Ltd., Abbott, Tridema Engineering S.r.L., Erba Group, ratiolab, Maccura Biotechnology Co., Ltd., Bioline Technologies, SYCOmed e.K., Siemens Healthcare GmbH, Zymed, F. Hoffmann-La Roche Ltd., and Rayto Life & Analytical Sciences Co., Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.